Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07089043 · ClinicalTrials.gov registry record · Phase 2

A Study in Subjects With Neurogenic Orthostatic Hypotension

A Phase 2 study of Neurogenic Orthostatic Hypotension, sponsored by CuraSen Therapeutics.

Recruiting
Registry status
Phase 2
Development phase
12
Enrollment target
4
Study locations

NCT07089043 is a Phase 2 study of Neurogenic Orthostatic Hypotension that is actively recruiting participants, run by CuraSen Therapeutics. The registered enrollment target is 12 participants, below the 227-participant average among 4 other Neurogenic Orthostatic Hypotension trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07089043, a Phase 2 study of Neurogenic Orthostatic Hypotension, is actively recruiting participants, sponsored by CuraSen Therapeutics.

RECRUITING
Registry status
Phase 2
Development phase
12 participants
Enrollment target
4
Study locations

Study Summary

This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

Conditions Studied

Neurogenic Orthostatic Hypotension

Interventions

  • DRUG Placebo
  • DRUG CST-3056

Study Locations (4)

Michigan

  • CuraSen Investigational Site - Farmington Hills

New Jersey

  • CuraSen Investigational Site - Eatontown

New York

  • CuraSen Investigational Site - New York

Tennessee

  • CuraSen Investigational Site - Nashville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-09-12
Est. Completion 2026-03-31
Phase Phase 2

Sponsor

CuraSen Therapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07089043

The ClinicalTrials.gov registry entry for NCT07089043 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 4 other Neurogenic Orthostatic Hypotension trials with a reported enrollment target (95% lower). The listed sponsor is CuraSen Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neurogenic Orthostatic Hypotension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07089043 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Michigan, New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT07089043 about?

NCT07089043 is a clinical study titled "A Study in Subjects With Neurogenic Orthostatic Hypotension". This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

What is the current status of trial NCT07089043?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2025-09-12. Estimated completion is 2026-03-31.

What conditions does trial NCT07089043 study?

This clinical trial studies the following conditions: Neurogenic Orthostatic Hypotension.

What interventions are being tested in trial NCT07089043?

The interventions under investigation include: Placebo (DRUG), CST-3056 (DRUG).

Who is sponsoring clinical trial NCT07089043?

This trial is sponsored by CuraSen Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07089043 being conducted?

This trial has 4 study locations across Michigan, New Jersey, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neurogenic Orthostatic Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Neurogenic Orthostatic Hypotension

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.